Depression Treatment Industry Supply Chain Analysis, Growth, Top Companies & Business Development Report by 2033

Emergen Research Logo

Emergen Research Logo

An increase in the number of people suffering from depression & a rise in minimal side-effect therapies will drive the demand for Depression Treatment market.

CANADA, BC, VANCOUVER, October 17, 2021 /EINPresswire.com/ — The global Depression Treatment Market is forecasted to be worth USD 16.06 Billion by 2027, according to a current analysis by Emergen Research. The growing incidence of mental health and depression is creating a demand for the market. Growth in the geriatric population and the rise in diseases such as anxiety disorders, phobia, and dementia will impact market growth. The low cost of the medication, coupled with affordable therapies, are expected to propel the growth of the Depression Treatment market. The report studies the historical data of the Depression Treatment market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The Global Depression Treatment Market report provides full coverage of the companies’ data, including details about their production and manufacturing capacity, product portfolio, business overview, revenue, gross profit margins, sales network and distribution channel, financial standing, and market position.
A major driving factor of the market is a surge in generic drug manufacturers. The lower cost of antidepressants and other drugs has encouraged people to opt for the treatment. Moreover, a rise in awareness about the treatment is also encouraging people to opt for the procedure. Rising awareness has led people to gather more knowledge about the disease and get rid of the old stigma attached to it. People are understanding the need for treatment and opting for it for a healthier lifestyle.

To get a sample copy of the Global Depression Treatment Market report, visit @ https://www.emergenresearch.com/request-sample/191

However, factors such as the expiration of the patent of drugs and the adoption of other treatments like the herbal treatment are expected to hamper the depression treatment market growth. Support from the government for the deployment of organizations and groups to help depressed patients will also drive depression treatment market demand.

The report also studies business strategies and strategic alliances undertaken by companies to gain a robust footing in the market. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. The comprehensive analysis of the competitive landscape offers the readers a deeper understanding about the competitors.

Top competitors of the Depression Treatment Market profiled in the report include:
• Pfizer, Inc., AstraZeneca, Plc, GlaxoSmithKline Plc, Eily, Lilly, and Company, Allergan Plc, Takeda Pharmaceutical Company Limited, Intellipharmaceutics International, Inc., Otsuka Holdings Co. Ltd., H.Lundbeck A/S, and Apotex, Inc., among others.

Key Highlights From The Report
• In October 2020, a global biotech company, ATAI Life Sciences, has launched Viridia Life Sciences for the development of formulations of N, N-dimethyltryptamine (DMT) to investigate the efficiency of digital therapeutics with resistant depression.
• Antipsychotics treatment has been used to treat depressive disorders. The medicine was used in combination with antidepressants and became the choice of treatment for depressed patients who had psychotic symptoms. The antipsychotic treatment was done to treat symptoms such as delusions, hallucinations, or marina symptoms. It is also used to treat bipolar depression.
Market Overview:
The research report on the Depression Treatment market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Depression Treatment business sphere.

To learn more details about the Global Depression Treatment Market report, visit @ https://www.emergenresearch.com/industry-report/depression-treatment-market
The report aims to deliver a comprehensive understanding of the Depression Treatment market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.

Regional Analysis of the Depression Treatment Market:
• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

For the purpose of this report, Emergen Research has segmented into the global Depression Treatment Market on the basis of drug type, application, end-user, distribution channel, and region:
• Drug Type Outlook (Revenue, USD Billion; 2017-2027)
o Antidepressants
1. Selective Serotonin Reuptake Inhibitors (SSRIs)
2. Selective Norepinephrine Reuptake Inhibitors (SNRIs)
3. Serotonin Modulators
4. Tricyclic & Tetracyclic Antidepressants
5. Atypical Antidepressants
o Antipsychotics
o Others
• Application Outlook (Revenue, USD Billion; 2017-2027)
o Major Depressive Disorder (MDD)
o Bipolar Disorder
o Postpartum Depression
o Premenstrual Dysphoric Disorder (PMDD)
o Dysthymic Disorder
o Seasonal Affective Disorder (SAD)
o Others
• End-User Outlook (Revenue, USD Billion; 2017-2027)
o Hospitals
o NGOs
o Mental Health Centers
o Asylums
o Others
• Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
o Hospitals Pharmacies
o Retail Pharmacies
o Online

Proceed To Buy: https://www.emergenresearch.com/select-license/191

Table of Content
Chapter 1. Methodology & Sources
1.1. Alopecia Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Alopecia Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Alopecia Market Segmentation & Impact Analysis
4.1. Alopecia Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Alopecia Market indicators analysis
4.2.2. Alopecia Market drivers analysis
4.2.2.1. Rapid urbanization and industrialization
4.2.2.2. Stringent government regulations regarding carbon emissions
4.2.2.3. Increasing prevalence of respiratory diseases
4.2.2.4. Rising need to enhance indoor air quality
4.2.3. Alopecia Market restraints analysis
4.2.3.1. High cost associated with the maintenance of Alopecia products
4.2.3.2. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continued….

Key Benefits of Buying the Global Depression Treatment Report:
• Comprehensive analysis of the changing competitive landscape
• Assists in decision making processes for the businesses along with detailed strategic planning methodologies
• The report offers an 8-year forecast and assessment of the Global Depression Treatment Market
• Helps in understanding the key product segments and their estimated growth rate
• In-depth analysis of market drivers, restraints, trends, and opportunities
• Comprehensive regional analysis of the Global Depression Treatment Market

Key Questions Answered in the Report:
What is the growth rate of the Depression Treatment market? What is the anticipated market valuation of Depression Treatment industry by 2027?
What are the key growth driving and restraining factors of the Depression Treatment market?
Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/191
Read similar reports by Emergen Research:

Nanopharmaceutical Drugs Market @: https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market

Clinical Perinatal Software Market @: https://www.emergenresearch.com/industry-report/clinical-perinatal-software-market

Human Microbiome Modulators Market @: https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market

In Silico Drug Discovery Market @: https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Research Antibodies Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2034

Emergen Research Logo

Emergen Research Logo

A rise in research activities in the neurobiology and stem cells’ field is one of the significant factors influencing the research antibodies market growth.

CANADA, BC, VANCOUVER, October 17, 2021 /EINPresswire.com/ — The global research antibodies market is projected to be worth USD 5,325.8 Million by 2027, according to a current analysis by Emergen Research. The market for research antibodies is witnessing a high demand due to its growing application in neurobiology, infectious diseases, oncology, stem cells, and immunology, among others. Increased investments in research in the field of stem cells is also a crucial growth factor of the Research Antibodies market. The report studies the historical data of the Research Antibodies market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The Global Research Antibodies Market report provides full coverage of the companies’ data, including details about their production and manufacturing capacity, product portfolio, business overview, revenue, gross profit margins, sales network and distribution channel, financial standing, and market position.

Heavy investments in research and development activities is critical for boosting the growth of the Research Antibodies market. Increased support from the government for genomic and proteomic research is also encouraging market growth. Genomic technologies are being used to understand the genetic factors involved in deaths. The overall expenditure in the U.S. on healthcare R&D was USD 182.30 billion in 2017. However, stringent regulations for the manufacture of antibodies and adherence to these regulations are limiting the Research Antibodies market growth.

To get a sample copy of the Global Research Antibodies Market report, visit @ https://www.emergenresearch.com/request-sample/192

Another factor driving the demand for the market is an increased incidence of neurodegenerative diseases such as Multiple Sclerosis, Huntington’s disease, and Parkinson’s. These diseases have a severe impact on human health, and the growing incidence is creating a need for effective therapies. The advancement in technology and the growing geriatric population is also having a positive impact on market growth. The rapid surge in the number of cancer patients all across the globe has also propelled their research activities. There are several public and private companies that have projects in pipelines to come up with effective therapy for the disease.

Market Overview:
The research report on the Research Antibodies market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Research Antibodies business sphere.

Key Highlights From The Report
• In January 2020, a leading market player, Abcam PLC, announced the acquisition of the Immunology and Proteomics business of Expedeon that comprises TGR Biosciences and Innova. The acquisition will provide Abcam access to Expedeon's immunology and proteomics products and support.
• Primary antibodies, in immunoassays, are of major importance to bind to the target antigen. These antibodies bind those antigen, protein, or any substance that is intended to be researched or studied.
• Western blots have the capacity to detect the protein’s pictogram level in a sample. It also enables it to be used in several applications, such as an effective diagnostic tool. It helps in direct labeling of primary antibodies, removing any need for secondary antibodies.

The report also studies business strategies and strategic alliances undertaken by companies to gain a robust footing in the market. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. The comprehensive analysis of the competitive landscape offers the readers a deeper understanding about the competitors.

Top competitors of the Research Antibodies Market profiled in the report include:
• Lonza Group, Becton, Dickinson and Company, Agilent Technologies, Bio-Rad Laboratories, Abcam PLC, PerkinElmer, Inc., Thermo Fisher Scientific, Merck Millipore, F.Hoffmann-La Roche AG, and Cell Signaling Technology Inc., among others.

To learn more details about the Global Research Antibodies Market report, visit @ https://www.emergenresearch.com/industry-report/research-antibodies-market

The report aims to deliver a comprehensive understanding of the Research Antibodies market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.

Regional Analysis of the Research Antibodies Market:
• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Emergen Research has segmented the global research antibodies market on the basis of antibody type, product, application, technology, end-users, and region:
• Antibody Type Outlook (Revenue, USD Million; 2017-2027)
o Monoclonal
o Polyclonal
• Product Outlook (Revenue, USD Million; 2017-2027)
o Primary Antibodies
o Secondary Antibodies
• Application Outlook (Revenue, USD Million; 2017-2027)
o Oncology
o Infectious Diseases
o Stem Cells
o Neurobiology
o Immunology
o Others
• Technology Outlook (Revenue, USD Million; 2017-2027)
o Western Blotting
o Flow Cytometry
o Immunofluorescence
o Immunohistochemistry
o Enzyme-linked Immunosorbent Assay
o Immunoprecipitation
o Others

• End-Users Outlook (Revenue, USD Million; 2017-2027)
o Pharmaceutical & Biopharmaceutical Firms
o Academic & Research Institutes
o Contract Research Organizations

Key Benefits of Buying the Global Research Antibodies Report:
• Comprehensive analysis of the changing competitive landscape
• Assists in decision making processes for the businesses along with detailed strategic planning methodologies
• The report offers an 8-year forecast and assessment of the Global Research Antibodies Market
• Helps in understanding the key product segments and their estimated growth rate
• In-depth analysis of market drivers, restraints, trends, and opportunities
• Comprehensive regional analysis of the Global Research Antibodies Market

Proceed To Buy: https://www.emergenresearch.com/select-license/192
Table of Content
Chapter 1. Methodology & Sources
1.1. Alopecia Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Alopecia Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Alopecia Market Segmentation & Impact Analysis
4.1. Alopecia Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Alopecia Market indicators analysis
4.2.2. Alopecia Market drivers analysis
4.2.2.1. Rapid urbanization and industrialization
4.2.2.2. Stringent government regulations regarding carbon emissions
4.2.2.3. Increasing prevalence of respiratory diseases
4.2.2.4. Rising need to enhance indoor air quality
4.2.3. Alopecia Market restraints analysis
4.2.3.1. High cost associated with the maintenance of Alopecia products
4.2.3.2. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continued….

Key Questions Answered in the Report:

What is the growth rate of the Research Antibodies market? What is the anticipated market valuation of Research Antibodies industry by 2027?
What are the key growth driving and restraining factors of the Research Antibodies market?
Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
Request customization of the report: https://www.emergenresearch.com/request-for-customization/192
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Read similar reports by Emergen Research:

Nanopharmaceutical Drugs Market @: https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market

Clinical Perinatal Software Market @: https://www.emergenresearch.com/industry-report/clinical-perinatal-software-market

Human Microbiome Modulators Market @: https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market

In Silico Drug Discovery Market @: https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

FINAL DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Generac Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – GNRC

SAN DIEGO, Oct. 16, 2021 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Generac Holdings Inc. (NYSE: GNRC) securities between February 23, 2021 and July 29, 2021, both dates inclusive (the “Class Period”) have until this upcoming Tuesday, October 19, 2021, to seek appointment as lead plaintiff in Khami v. Generac Holdings Inc., No. 21-cv-06777, the Generac class action lawsuit. The Generac class action lawsuit charges Generac and certain of its top executives with violations of the Securities Exchange Act of 1934. The Generac class action lawsuit was commenced on August 20, 2021 in the Central District of California. A similar lawsuit, Procter v. Generac Holdings Inc., No. 21-cv-07009, is also pending in the Central District of California.

If you wish to serve as lead plaintiff of the Generac class action lawsuit, please provide your information by clicking here. You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com. Lead plaintiff motions for the Generac class action lawsuit must be filed with the court no later than this upcoming Tuesday, October 19, 2021.

CASE ALLEGATIONS: The Generac class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) Generac’s portable generators posed an unreasonable risk of injury to users and the public; (ii) as a result, at least seven finger amputations and one crushed finger had been reported to Generac; (iii) thus, Generac would face increased regulatory scrutiny; (iv) Generac would end sales in its Generac® and DR® 6500 Watt and 8000 Watt portable generators in the United States and Canada in June 2021; (v) Generac would recall its Generac® and DR® 6500 Watt and 8000 Watt portable generators in the United States and Canada; (vi) the end of sales and the recall would occur before Generac’s noted hurricane and wildfire seasons and following the Texas outage – periods Generac has touted for sales; and (vii) consequently, defendants’ public statements and statements to journalists were materially false and/or misleading at all relevant times.

On July 29, 2021, the United States Consumer Product Safety Commission, Health Canada, and the Organisation for Economic Co-operation and Development announced the Generac portable generator recall, revealing that Generac had received reports of seven finger amputations and one finger crushing. On this news, Generac’s stock price fell approximately 7%, damaging investors.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Generac securities during the Class Period to seek appointment as lead plaintiff in the Generac class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Generac class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Generac class action lawsuit. An investor’s ability to share in any potential future recovery of the Generac class action lawsuit is not dependent upon serving as lead plaintiff.

ABOUT ROBBINS GELLER RUDMAN & DOWD LLP: With 200 lawyers in 9 offices nationwide, Robbins Geller Rudman & Dowd LLP is the largest U.S. law firm representing investors in securities class actions. Robbins Geller attorneys have obtained many of the largest shareholder recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. The 2020 ISS Securities Class Action Services Top 50 Report ranked Robbins Geller first for recovering $1.6 billion for investors last year, more than double the amount recovered by any other securities plaintiffs’ firm. Please visit http://www.rgrdlaw.com for more information.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Contact:
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, San Diego, CA 92101
J.C. Sanchez, 800-449-4900
jsanchez@rgrdlaw.com


Primary Logo


Source: EIN Presswire

Westminster Barracks // Fire Investigation

VSP News Release-Incident

 

STATE OF VERMONT

DEPARTMENT OF PUBLIC SAFETY

VERMONT STATE POLICE

 

NEWS RELEASE

       

CASE#: 21B104546

RANK/TROOPER FULL NAME: Detective Sgt. Stephen DiGregorio                      

    

STATION: Williston                     

CONTACT#: (802) 878-7111

 

DATE/TIME: 10/15/2021 – 2000 Hours

INCIDENT LOCATION: Town Hill Road & VT Route 9, Marlboro

 

SUMMARY OF INCIDENT:

On October 15, 2021 at approximately 2000 hours, the Marlboro Fire Department

received a report of a structure fire located near the intersection of Town

Hill Road and VT Route 9 in Marlboro. The Marlboro Fire Department responded to

the location and observed fire emerging from beneath the structure. Fire

suppression efforts were conducted which saved the structure. The single story

wooden building was unoccupied and no injuries were reported.

 

As part of Marlboro Fire Chief Rusty Sage’s assessment of the fire, he contacted

the Department of Public Safety Fire and Explosion Investigation Unit (FEIU) for

assistance in determining the origin and cause of the fire.

 

FEIU members responded to Marlboro and conducted a scene examination.  The cause

of the fire is under investigation but is believed to be the result of direct

human involvement. The building sustained moderate damage from fire, heat,

smoke, and water.

 

Anyone with information regarding this incident is asked to contact Detective

Sgt. Stephen DiGregorio of the Williston State Police Barracks at 802-878-7111.

People with information may also contact the Vermont Arson Tip Award Program at

800-32-ARSON. The Arson Tip Award Program is a separate entity from the state

police, and through funding from insurance companies offers a reward of up to

$5,000 for information that leads to an arrest in this case.

 

 

 

 

 


Source: EIN Presswire

FINAL DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that PayPal Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – PYPL

SAN DIEGO, Oct. 16, 2021 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers of PayPal Holdings, Inc. (NASDAQ: PYPL) securities between February 9, 2017 and July 28, 2021, both dates inclusive (the “Class Period”), have until this upcoming Tuesday, October 19, 2021, to seek appointment as lead plaintiff in Kang v. PayPal Holdings, Inc., No. 21-cv-06468. The PayPal class action lawsuit charges PayPal and certain of its top executives with violations of the Securities Exchange Act of 1934. The PayPal class action lawsuit was commenced on August 20, 2021 and is pending in the Northern District of California.

If you wish to serve as lead plaintiff of the PayPal class action lawsuit, please provide your information by clicking here. You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com. Lead plaintiff motions for the PayPal class action lawsuit must be filed with the court no later than this upcoming Tuesday, October 19, 2021.

CASE ALLEGATIONS: In 2015, PayPal settled regulatory claims with the Consumer Financial Protection Bureau (“CFPB”) arising from certain of its business practices related to PayPal Credit between 2011 and 2015. Following this incident, according to the PayPal class action lawsuit, PayPal repeatedly asserted that it was remediating issues with its PayPal Credit business practices in accordance with its 2015 settlement with the CFPB.

The PayPal class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) PayPal had deficient disclosure controls and procedures; (ii) as a result, PayPal’s business practices with respect to PayPal Credit remained non-compliant with applicable laws and/or regulations; (iii) PayPal’s practices regarding payment of interchange rates related to its debit cards were likewise non-compliant with applicable laws and/or regulations; (iv) accordingly, PayPal’s revenues derived from its PayPal Credit and debit card practices were in part the subject of improper conduct and thus unsustainable; (v) this subjected PayPal to an increased risk of regulatory investigation and enforcement; and (vi) consequently, PayPal’s public statements were materially false and misleading at all relevant times.

On July 29, 2021, PayPal disclosed investigations by the U.S. Securities and Exchange Commission (“SEC”) and the CFPB. Specifically, PayPal disclosed receipt of a Civil Investigative Demand from the CFPB related “to the marketing and use of PayPal Credit in connection with certain merchants that provide educational services”; and that PayPal has “responded to subpoenas and requests for information received from the [SEC] relating to whether the interchange rates paid to the bank that issues debit cards bearing our licensed brands were consistent with Regulation II of the Board of Governors of the Federal Reserve System, and to the reporting of marketing fees earned from the Company’s branded card program.” On this news, PayPal’s stock price fell more than 6%, damaging investors.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased PayPal securities during the Class Period to seek appointment as lead plaintiff in the PayPal class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the PayPal class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the PayPal class action lawsuit. An investor’s ability to share in any potential future recovery of the PayPal class action lawsuit is not dependent upon serving as lead plaintiff.

ABOUT ROBBINS GELLER RUDMAN & DOWD LLP: With 200 lawyers in 9 offices nationwide, Robbins Geller Rudman & Dowd LLP is the largest U.S. law firm representing investors in securities class actions. Robbins Geller attorneys have obtained many of the largest shareholder recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. The 2020 ISS Securities Class Action Services Top 50 Report ranked Robbins Geller first for recovering $1.6 billion for investors last year, more than double the amount recovered by any other securities plaintiffs’ firm. Please visit http://www.rgrdlaw.com for more information.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Contact:
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, San Diego, CA 92101
J.C. Sanchez, 800-449-4900
jsanchez@rgrdlaw.com


Primary Logo


Source: EIN Presswire

Delaware Natural Resources Police Investigate Motor Vehicle Accident with Injuries at Abessinio Stadium

Wilmington State Parks Office

Delaware Natural Resources Police and Wilmington Department of Police are investigating a vehicle accident with serious injuries that occurred Friday afternoon at the Abessinio Stadium, located within Wilmington State Parks.

A 16-year-old Wilmington man failed to maintain control of his 2016 Jeep Grand Cherokee while reversing from a parking space. The Jeep, traveling in reverse, first struck two parked vehicles, a 2012 Hyundai Accent and a 2009 Cadillac Escalade. The Jeep then continued in reverse striking two individuals that were sitting on chairs behind the Escalade trapping a 65-year-old Dover woman under the Jeep.

The female victim had to be extricated from beneath the Jeep by Wilmington Fire Department personnel that arrived on scene. She was then flown to Christiana Hospital by Delaware State Police’s aviation unit. At this time, she is listed in serious but stable condition with multiple, non-life-threatening injuries.

The second victim seated in the parking lot is a 63-year-old Middletown man who was transported to Christiana Hospital by ambulance for leg injuries. He has since been treated and released.

The driver of the Hyundai, a 51-year-old Smyrna man, who was seated in his parked car was transported to Christiana Hospital for injuries to his leg and back. He has since been treated and released. A passenger in the Hyundai, a 68-year-old Smyrna man, was uninjured in the accident.

The driver of the Jeep was uninjured in this accident.

This accident remains under investigation and no charges have been filed at this time. Anyone with information regarding this incident should contact Cpl. David Redgraves at david.redgraves@delaware.gov.

About DNREC

The Delaware Department of Natural Resources and Environmental Control protects and manages the state’s natural resources, protects public health, provides outdoor recreational opportunities and educates Delawareans about the environment. For more information, visit the website and connect with @DelawareDNREC on Facebook, Twitter or LinkedIn.

Media Contacts: Nikki Lavoie, nikki.lavoie@delaware.gov; Cpt. John McDerby, john.mcderby@delaware.gov

###


Source: EIN Presswire

Middlesex- Burglary Information

STATE OF VERMONT

DEPARTMENT OF PUBLIC SAFETY

VERMONT STATE POLICE

 

NEWS RELEASE

       

CASE#: 21A304077

RANK/TROOPER FULL NAME: Trooper Armin Nukic                            

STATION: Middlesex Barracks                   

CONTACT#: (802)229-9191

 

DATE/TIME: 10/16/2021 at approximately 0032hrs

INCIDENT LOCATION: PK Coffee at 40 Foundry St #4, Waterbury Village Historic District, VT 05676

VIOLATION: Burglary and theft

 

ACCUSED: Unknown Male – White Male possibly in late 20’s to early 30’s. Clean Shaven with short hair, wearing a black cap, pull over sweater (khaki color) and pants (black).                                         

 

SUMMARY OF INCIDENT: On October 15, 2021, at approximately 0032hrs, the Vermont State Police received a report of a burglary and theft from PK Coffee in Waterbury, VT. The general manager of PK coffee, Linnae Coran, advised a burglary had taken place and money was stolen. Anyone with information regarding this case is asked to reach out to Middlesex Barracks at (802)229-9191 or email Armin.Nukic@vermont.gov

 

Trooper Armin Nukic

Vermont State Police

Troop A-Middlesex

1080 US RT 2

Middlesex, VT 05602

Phone: 802-229-9191

Fax: 802-229-2648

 


Source: EIN Presswire

The LoveChain: A New Social Media Platform built on the Algorand blockchain

Sydney, Oct. 16, 2021 (GLOBE NEWSWIRE) — Australia, Sydney, The LoveChain is a new Social Media platform built on the Algorand blockchain that rewards its users with its native token. Its initial version will be released in the coming weeks, heralding the first steps towards a new era of interconnectivity.

The LoveChain is set to radically transform the Social Media landscape, allowing for capitalisation on the value of digital content creation. The app is tackling some of the all too apparent issues that have plagued users of the Social Media behemoths of our time – beginning with ownership of their data and the right to sell or protect that information as users see fit. 

Adam Mazzaferro (Founder) Remarks:

The LoveChain founder Adam Mazzaferro said, “News reports and research confirm all the big tech social media platforms are toxic and harmful to mental health. They exploit their users and there is evidence they are contributing to a breakdown in social cohesion worldwide.

The LoveChain is a radical alternative that gives every user control over their data and making social media more about constructive and positive engagement that celebrates the things and people we love. People are tired of their life events being exploited and controlled”.

The platform aims to empower its users from the get-go through its two token systems- the governance aspect of the platform and the rewards program for those creating and sharing content within the app. 

“Big-tech owned social media platforms don’t share the billions of dollars in revenues they generate from advertisers with their users. We are going to give back to our users and reward them for their time and contributions to the platform”, Adam added.

The ‘LOV’ token serves holders and users by allowing active participation in the governance and direction of The LoveChain community and is essentially set to grow in value as users flock to the ecosystem.

The token will be listed on major exchanges for purchase, but it will also be redeemable in the future for discounts on goods and services through The LoveChain’s marketplace (not included in the initial release), and as such, it’s another avenue for investors to partake in the success of The LoveChain community.

A ‘burn’ of the token supply is intended to be implemented based on a fixed quarterly percentage of the revenue pool.

A much larger pool of 8 billion ‘LOVR’ tokens acts as the rewards program. Users of The LoveChain app can earn these reward tokens by gaining followers, creating and sharing content on the app, growing one’s online presence and clout, and even volunteering one’s data to advertisers.

Rewards are automatically allocated to the users’ integrated digital wallets. This ultimately means very quantifiable benefits for users simply for participating. The value of this pool is backed by a sizable 30% to 40% portion of the foundation’s topline revenue stream and distributed by way of open-source algorithms.

The Algorand blockchain was selected as the infrastructure for The LoveChain’s digital construction, which is among the most technically comprehensive locations for developers currently, capable of a thousand transactions per second.

“Social media is ripe for disruption, and it is exciting to see The LoveChain building a new kind of platform that prioritizes the things users want most today, like ownership of their own data and control over its monetization” said Giuliana Berchicci, Director of Business Solutions at Algorand. “The Algorand blockchain was designed to facilitate the kind of speed, security, and scalability that innovative platforms like The LoveChain need, and it is sure to be an exciting launch.”

Though time will tell how effectively The LoveChain foundation adheres to the future roadmap and succeeds in onboarding new users, the platform is primed to make off with a substantial portion of traditional Social Media platform users very shortly. With its unique emphasis on ‘Sharing the Love’, The LoveChain aims to establish itself as a household name in the coming years.

The launching date will be announced soon.

Telegram: https://t.me/Lovechaintg

Facebook: https://www.facebook.com/thelovechain.io

Instagram: https://www.instagram.com/thelovechain.io

Twitter: https://twitter.com/the_lovechain

Media contact

Company: The LoveChain

Contact Name: Fiorella Bonfiglioli

E-mail: info@thelovechain.io

Website: https://www.thelovechain.io

Source Link




Source: EIN Presswire

Soulless Solomon & The Daring Future of Solana NFT’s

Vancouver, Oct. 16, 2021 (GLOBE NEWSWIRE) — Anyone who’s spent any time within earshot of the technology, finance, or cryptocurrency industries lately – must’ve no doubt heard of NFT’s. More accurately known as, Non-Fungible Tokens. While the prime directive of NFT’s is quite high level, aiming to revolutionize the meaning of digital ownership – they’ve become exceedingly popular in artistic communities, who have taken to NFT’s as a way to create value, community and inject their artistic pursuits with an unprecedented amount of desirability with collectors and traders.

Soulless Solomon is proud to announce its arrival in this new wave, which has spawned an unprecedented self-sufficient economy of digital art that’s rapidly increasing in value.

Projects in recent memory, such as Ethereum’s CryptoPunks, have caught both mainstream and celebrity attention, drawing in collectors like finance giant Visa and mega-celebrities like Jay-Z and Logan Paul. The train doesn’t seem to be stopping anytime soon, as nearly every day we hear from new corporations and celebrities jumping aboard the NFT mission, and supporting projects and artist’s donating their talent to this burgeoning scene.

While Ethereum has long been the home for NFT projects, a fierce competitor is rearing its head and rapidly approaching in Solana – a rival blockchain that supports much quicker transaction speeds with a fraction of the per-transaction consumer cost. It’s being touted as the future for NFT’s, with designers and blockchain developers flocking to the space in droves, and rushing to be the Solana’s version of CryptoPunks.

The Souls behind Soulless Solomon

The newest upcoming project on the scene, aiming to dominate the Solana NFT space comes from a collective of artists and veteran blockchain developers, operating under the project moniker of Soulless Solomon. The project will be generating 7,777 unique artworks, hand drawn by an in-house team of artists, and holding a project “minting” that will see thousands of potential customers rushing to try to attain an original piece in this limited run.

The team behind the project has weaved an eerie, biblical prose into each work of art, instilling the project’s story with sardonic commentary on internet culture and technology, reminiscent of modern artists like street-art sensation Banksy. They intend to market the project to a vast community of NFT traders, and carry through on a project roadmap which will see the creation of unique merchandise, and custom assets for owners and traders to outfit their digital profiles.

If you’re looking to get in on the NFT trend, and believe Solana could be the next big hub for this new wave of frenzied art-collecting – this seems like the perfect project to jump aboard. The best way to get involved in the project is to join their Discord community, and stay up to date with the launch window and promotional giveaways leading up to the artwork minting.

Social Links

Discord: www.discord.gg/6YYrKhBEMy

Twitter: https://www.twitter.com/solomonsnft

Medium: https://medium.com/@soullesssolomon

Media Contact

Company: Soulless Media Ventures Inc.

Contact Name: Joseph Green

Address: 1169 Alberni Street, Vancouver, BC V6E 1A5, Canada

E-mail: support@soulless-solomon.com

Website: https://soulless-solomon.com/

Source link




Source: EIN Presswire

SHAFTSBURY BARRACKS/ MULTIPLE CHARGES

VSP News Release-Incident

 

STATE OF VERMONT

DEPARTMENT OF PUBLIC SAFETY

VERMONT STATE POLICE

 

NEWS RELEASE

       

CASE#: 21B302983

RANK/TROOPER FULL NAME: Trooper Grimes                            

STATION: Shaftsbury                    

CONTACT#: 802-442-5421

 

DATE/TIME: 10/15/21 approximately 2300 hours

INCIDENT LOCATION: Butternut Gutter, Arlington

VIOLATION: Aggravated Assault, Reckless Endangerment, Person Prohibited from

Possessing firearms

 

ACCUSED: Shane Leland                                              

AGE: 31

CITY, STATE OF RESIDENCE: Arlington, VT

 

 

 

SUMMARY OF INCIDENT: On 10/15/21 at approximately 2300 hours Troopers handled a

complaint of a verbal argument that turned physical and possibly involved the

pointing of a firearm. Investigation revealed that Leland engaged in a verbal,

then physical altercation with another male at his residence. At one point

during the incident a firearm was brandished and pointed at a male involved. On

10/16/21 at approximately 1100 hours Troopers arrived at the residence in

Arlington in an attempt to make contact with Leland concerning the incident. At

approximately 1245 hours Troopers took Leland into custody resulting from a car

stop. He was transported to the Shaftsbury barracks for processing. Leland was

subsequently lodged at the Marble Valley Correctional Center and held without

bail. He is due in Bennington Superior Court on 10/18/21 at 1230 hours to answer

to the charges.

 

 

COURT ACTION: Y

COURT DATE/TIME: 10/18/21 at 1230 hrs           

COURT: Bennington Superior

LODGED – LOCATION: MVCC   

BAIL: none/ held without

MUG SHOT: YES

 

 

 

 

 


Source: EIN Presswire